ACTRN12624000920594
Not yet recruiting
未知
Implementation of CardioVascular Disease Risk Assessment by Pharmacy in secondary care for high-risk ethnicities
Christchurch Hospital Pharmacy Department0 sites200 target enrollmentJuly 30, 2024
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Cardiovascular disease
- Sponsor
- Christchurch Hospital Pharmacy Department
- Enrollment
- 200
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •oMaori or Pacific Male\* aged 30 or above
- •oMaori or Pacific Female\* aged 40 or above
- •oLive in greater Christchurch area to ensure appropriate community follow up can be arranged.
- •(\*Sex at birth)
Exclusion Criteria
- •High risk CVD features that automatically define risk as \> 15%
- •oHeart failure
- •oCoronary or carotid artery disease from imaging (unlikely to have in community)
- •oeGFR \< 30 mL/min or \< 45mL/min with diabetes
- •oPrevious Cardiovascular event
- •oFamilial hypercholesterolaemia
- •oAge greater than 75 (as the PREDICT CVD RA tool is only validated for \< 75 years)
- •oPregnant / Breastfeeding
- •oNot appropriate due to clinical or emotional status (too unwell) or prognosis (short life expectancy)
- •Note: If deemed inappropriate due to current clinical status, this can be reassessed at a later date during their admission
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 4
A clinical trial for Heart Disease Risk assessment and treatment of patients with high risk.Health Condition 1: I00-I99- Diseases of the circulatory systemCTRI/2019/04/018723Dr Saurabha Nayak
Not yet recruiting
Not Applicable
Cardiovascular Disease (CVD) Risk Assessment and Lipid Lowering Treatment in Type 2 Diabetes Mellitus Patients Treated at Secondary and/or Tertiary Hospitals in KoreaKCT0004984Pfizer Upjohn Korea2,000
Active, not recruiting
Phase 1
CREATE. Cardiovascular Risk Evaluation and Attenuation of inflammation by early rosuvastatin TrEatment - CREATEEUCTR2006-001860-22-ISKarl Andersen
Recruiting
Not Applicable
Implementation of Cardiovascular Risk management for patients with Rheumatoïd Arthritis (I-CaRe)cardiovascular disease and atherosclerosis100110821000381610003216NL-OMON41344Jan van Breemen Instituut3,200
Recruiting
Not Applicable
Study of effect of yoga in reducing cardiovascular disease risks in communityCTRI/2017/09/009770Jawaharlal Institute of Post graduate Medical Education and Research JIPMER1,000